Use of adenosine antagonists in the treatment of bradyarrhythmia

Details Use of adenosine antagonists in the treatment of bradyarrhythmia Use of adenosine antagonists in the treatment of bradyarrhythmia

1987-04-10

1990-02-27

Killos, Paul J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514 9, 514253, 514265, A61K 4900

Patent

active

049044729

ABSTRACT:
A method to enhance the efficacy of cardioversion, defibrillation, cardiac pacing, and cardiopulmonary resuscitation and to treat post-resuscitation asystole, bradyarrhythmias, electromechanical dissociation, and hemodynamic collapse by administering to a human or animal an effective amount of an adenosine antagonist that competitively inhibits adenosine or that reduces the level of adenosine present in myocardial and vascular tissues and associated fluids.

REFERENCES:
patent: 4364922 (1982-12-01), Berne

Affiliated with

Also associated with

Rating

Use of adenosine antagonists in the treatment of bradyarrhythmia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of adenosine antagonists in the treatment of bradyarrhythmia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine antagonists in the treatment of bradyarrhythmia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-172759